Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience

Ann Rheum Dis. 2022 Oct;81(10):e188. doi: 10.1136/annrheumdis-2020-218528. Epub 2020 Jul 30.

¹ Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK asim.khan7@nhs.net.
² Rheumatology Department, North Middlesex University Hospital NHS Trust, London, UK.
³ Critical Care Department, North Middlesex University Hospital NHS Trust, London, UK.
⁴ Pharmacy Department, North Middlesex University Hospital NHS Trust, London, UK.
⁵ Rheumatology Department, University College London Hospitals NHS Foundation Trust, London, UK.

No abstract available

Keywords: antirheumatic agents; biological therapy; cytokines; epidemiology; inflammation.

Publication types